{"id":185005,"date":"2025-11-24T13:21:10","date_gmt":"2025-11-24T11:21:10","guid":{"rendered":"https:\/\/www.ainia.com\/?p=185005"},"modified":"2026-04-02T13:18:12","modified_gmt":"2026-04-02T12:18:12","slug":"new-market-needs-in-european-formulation-of-api-pharmaceutical-ingredients","status":"publish","type":"post","link":"https:\/\/www.ainia.com\/en\/ainia-news\/new-market-needs-in-european-formulation-of-api-pharmaceutical-ingredients\/","title":{"rendered":"New Market Needs in European Formulation of API Pharmaceutical Ingredients"},"content":{"rendered":"

[vc_row][vc_column][vc_column_text css=\u201d\u201d]<\/span><\/span><\/span><\/span><\/span><\/span><\/span>The European pharmaceutical sector is undergoing a profound transformation. Alongside traditional challenges\u2014such as strict regulation or equitable access to treatments\u2014new demands are emerging, driven by sustainability, digitalisation and personalisation. Within this context, the formulation of API pharmaceutical ingredients<\/strong> has become a strategic priority: it must not only ensure safety and efficacy but also align with the environmental, regulatory and technological expectations of the market.<\/span>
\n This shift is reshaping how <\/span>api pharmaceutical<\/span><\/i> development and manufacturing are approached across Europe.<\/span>\u00a0<\/span><\/p>\n

Emerging Needs in Pharmaceutical Ingredient Formulation<\/span><\/b>\u00a0<\/span><\/h2>\n

Today, pharmaceutical formulation cannot be understood without recognising the role of microorganisms as natural biofactories capable of producing active ingredients,<\/a> <\/strong>excipients and other therapeutically relevant molecules. This trend is closely linked to the evolution of biotechnologies applied to the pharmaceutical industry.<\/span>\u00a0<\/span><\/p>\n

To guarantee the highest levels of safety and quality throughout the process, these innovative techniques must be adapted to Good Manufacturing Practices (GMP)<\/a>,<\/strong> ensuring full control of process design, robustness and safety<\/span>\u00a0<\/span><\/p>\n

3D Printing of Medicines\u00a0<\/strong><\/h3>\n

3D printing applied to pharmaceutical manufacturing enables far more individualised therapeutic solutions:<\/span>\u00a0<\/span><\/p>\n